The Problem of Unpatentable  Innovation in Pharmaceuticals

The Problem of Unpatentable Innovation in Pharmaceuticals

As capital intensive public goods, pharmaceuticals are likely to receive inefficiently-low investment in the absence of government intervention. The patent system functions well to promote innovation in the pharmaceutical industry. However, because innovation in...
iLawyer

iLawyer

Artificially intelligent technologies have entered the United States legal market — and it appears they are here to stay. In 2019 alone, investments in legal technology amounted to over 1.2 billion dollars. Presently, AI legal tools fall into six major...